A new study raises the odds that a strategy already successful against some cancers may be deployed against Alzheimer’s. The research, which highlights the role of an immune system “checkpoint” molecule, showed improved cognition in tests with mice.

From Vijay Kuchroo and colleagues, co-first authors Kimitoshi Kimura and Ayshwarya Subramanian. Featured by the Harvard Gazette.